Overall, the findings herein reveal that in adolescence, genetically slow nicotine metabolizers are more likely to quit smoking than normal nicotine metabolizers. A greater understanding of the factors underpinning cessation in adolescence may improve quit rates early in the course of smoking onset, reducing subsequent long-term illnesses and mortality that result from cigarette smoking.